Prot #63623872FLZ2002: A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adolescent, Adult, and Elderly Hospitalized Patients W

Project: Research project

Project Details

StatusFinished
Effective start/end date1/19/168/31/18

Funding

  • Janssen Research & Development, LLC (Prot #63623872FLZ2002)